Summit Therapeutics (SMMT) Notes Payables (2021 - 2024)
Summit Therapeutics' (SMMT) quarterly Notes Payables came in at $24.5 million in Q3 2024, down 75.5% YoY from $100.0 million in Q4 2023, and down 75.5% on a QoQ basis from $100.0 million in Q2 2024.
Summit Therapeutics (SMMT) Notes Payables (2021 - 2024) Analysis & Trends
Summit Therapeutics (SMMT) has 4 years of Notes Payables data on file, last reported at $24.5 million in Q3 2024.
- Quarterly Notes Payables fell 75.5% year-over-year to $24.5 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $24.5 million (down 75.5% YoY) and the FY2022 annual result came in at $19.8 million, changed N/A from the prior year.
- Notes Payables fell to $24.5 million in Q3 2024, from $100.0 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $100.0 million in Q3 2023 to a low of $19.8 million in Q4 2022.
- A 4-year average of $59.8 million and a median of $55.0 million in 2021 frame the typical range for Notes Payables.
- The widest YoY moves for Notes Payables: up 75.5% in 2024, down 75.5% in 2024.
- Tracing SMMT's Notes Payables over 4 years: stood at $55.0 million in 2021, then slumped by 64.03% to $19.8 million in 2022, then soared by 405.82% to $100.0 million in 2023, then plunged by 75.5% to $24.5 million in 2024.
- The last three Notes Payables figures came in at $24.5 million (Q3 2024), $100.0 million (Q2 2024), and $100.0 million (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Summit Therapeutics | 10.59 Bn | 9.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 24.50 Mn |
| Jun 30, 2024 | 100.00 Mn |
| Sep 30, 2023 | 100.00 Mn |
| Dec 31, 2022 | 19.77 Mn |
| Mar 31, 2021 | 54.96 Mn |